The pancreas can release compensatory insulin (insulin feedback) to restore the body to normal glucose homeostasis, however this insulin feedback may reactivate PI3K/AKT/mTOR signalling in tumours, thereby affecting the effect of targeted therapy.80 This evidence concerns the gene AKT1 and neoplasm.